The failure to prevent fraud (FTPF) offence poses risks across all industries, but pharmaceutical companies sit firmly in the spotlight, where data-driven models, intense commercial pressure and reliance on third parties create the very conditions the offence targets.
Filed under
Topics
Laws
Industries
